These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31844808)

  • 1. Autoantibodies Specific for Galactose-Deficient IgA1 in IgA Vasculitis With Nephritis.
    Suzuki H; Moldoveanu Z; Julian BA; Wyatt RJ; Novak J
    Kidney Int Rep; 2019 Dec; 4(12):1717-1724. PubMed ID: 31844808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of galactose-deficient IgA1 in Chinese children with IgA nephropathy, IgA vasculitis with nephritis, and IgA vasculitis.
    Tang M; Zhang X; Li X; Lei L; Zhang H; Ling C; Ni J; Lv J; Liu X; Chen X
    Clin Exp Nephrol; 2021 Jan; 25(1):37-43. PubMed ID: 32935202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis.
    Li Q; Yuan X; Shi S; Liu L; Lv J; Zhu L; Zhang H
    Clin Kidney J; 2023 Jan; 16(1):184-191. PubMed ID: 36726446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis.
    Zhang X; Xie X; Shi S; Liu L; Lv J; Zhang H
    Nephrol Dial Transplant; 2020 Dec; 35(12):2117-2123. PubMed ID: 31377786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galactose-deficient IgA1 in skin and serum from patients with skin-limited and systemic IgA vasculitis.
    Neufeld M; Molyneux K; Pappelbaum KI; Mayer-Hain S; von Hodenberg C; Ehrchen J; Barratt J; Suzuki Y; Sunderkötter C
    J Am Acad Dermatol; 2019 Nov; 81(5):1078-1085. PubMed ID: 30902725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV Inhibits Galactose-Deficient IgA1 Secretion
    Liu C; Li X; Shuai L; Dang X; Peng F; Zhao M; Xiong S; Liu Y; He Q
    Front Pharmacol; 2021; 12():658236. PubMed ID: 33935780
    [No Abstract]   [Full Text] [Related]  

  • 7. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.
    Yanagawa H; Suzuki H; Suzuki Y; Kiryluk K; Gharavi AG; Matsuoka K; Makita Y; Julian BA; Novak J; Tomino Y
    PLoS One; 2014; 9(5):e98081. PubMed ID: 24858067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
    Rizk DV; Saha MK; Hall S; Novak L; Brown R; Huang ZQ; Fatima H; Julian BA; Novak J
    J Am Soc Nephrol; 2019 Oct; 30(10):2017-2026. PubMed ID: 31444275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro.
    Lin L; Shen J; Wu X; You Y; Li S
    J Vis Exp; 2023 Oct; (200):. PubMed ID: 37902367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA vasculitis with nephritis: update of pathogenesis with clinical implications.
    Hastings MC; Rizk DV; Kiryluk K; Nelson R; Zahr RS; Novak J; Wyatt RJ
    Pediatr Nephrol; 2022 Apr; 37(4):719-733. PubMed ID: 33818625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy.
    Xie YX; He LY; Chen X; Peng XF; Ye MY; Zhao YJ; Yan WZ; Liu C; Shao J; Peng YM
    Int Urol Nephrol; 2016 Nov; 48(11):1855-1861. PubMed ID: 27465795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy.
    Reily C; Rice T; Crossman DK; Rizk DV
    J Autoimmun; 2022 Oct; 132():102883. PubMed ID: 35987175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
    Wada Y; Matsumoto K; Suzuki T; Saito T; Kanazawa N; Tachibana S; Iseri K; Sugiyama M; Iyoda M; Shibata T
    PLoS One; 2018; 13(11):e0206865. PubMed ID: 30388165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
    BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy.
    Moldoveanu Z; Suzuki H; Reily C; Satake K; Novak L; Xu N; Huang ZQ; Knoppova B; Khan A; Hall S; Yanagawa H; Brown R; Winstead CJ; O'Quinn DB; Weinmann A; Gharavi AG; Kiryluk K; Julian BA; Weaver CT; Suzuki Y; Novak J
    J Autoimmun; 2021 Mar; 118():102593. PubMed ID: 33508637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
    Suzuki H; Moldoveanu Z; Hall S; Brown R; Julian BA; Wyatt RJ; Tomana M; Tomino Y; Novak J; Mestecky J
    Contrib Nephrol; 2007; 157():129-33. PubMed ID: 17495450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort.
    Berthelot L; Jamin A; Viglietti D; Chemouny JM; Ayari H; Pierre M; Housset P; Sauvaget V; Hurtado-Nedelec M; Vrtovsnik F; Daugas E; ; Monteiro RC; Pillebout E;
    Nephrol Dial Transplant; 2018 Sep; 33(9):1579-1590. PubMed ID: 29126311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
    Zachova K; Jemelkova J; Kosztyu P; Ohyama Y; Takahashi K; Zadrazil J; Orsag J; Matousovic K; Galuszkova D; Petejova N; Mestecky J; Raska M
    J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy.
    Wang M; Lv J; Zhang X; Chen P; Zhao M; Zhang H
    Kidney Int Rep; 2020 Feb; 5(2):165-172. PubMed ID: 32043030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.